Results 21 to 30 of about 13,789 (243)

Safety and Efficacy of Tirofiban in Severe Ischemic Stroke Patients Undergoing Mechanical Thrombectomy

open access: yesJournal of Cardiovascular Development and Disease, 2022
Tirofiban has recently shown encouraging efficacy and safety among acute ischemic stroke (AIS) patients with mechanical thrombectomy (MT). However, the benefits of tirofiban varied among studies depending on the patient’s condition, which was often not ...
Lingxin Cai   +6 more
doaj   +2 more sources

Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke

open access: yesFrontiers in Neurology, 2022
BackgroundIntravenous thrombolysis and endovascular thrombectomy have been approved for acute ischemic stroke (AIS). However, only a minority of patients received these treatments in China.
Bin Han   +11 more
doaj   +2 more sources

Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

open access: yesFrontiers in Neuroscience, 2022
The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous ...
Yunzhu Liu   +7 more
doaj   +2 more sources

Comparison of safety and efficacy after emergency stenting in patients exhibiting intracranial atherosclerotic stenosis associated with large-vessel occlusion with and without intravenous infusion of tirofiban [PDF]

open access: yesCardiovascular and Interventional Radiology, 2023
Purpose Intracranial rescue stent angioplasty is a bailout strategy for acute stroke patients in cases of unsuccessful endovascular thrombectomy due to underlying atherosclerotic stenosis.
Berlis, Ansgar   +6 more
core   +2 more sources

Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease

open access: yesNeurology, 2023
Background and Objective To investigate the efficacy and safety of IV infusion of tirofiban before endovascular thrombectomy for patients with large vessel occlusion due to intracranial atherosclerotic disease.
Hongfei Sang   +22 more
semanticscholar   +1 more source

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.

open access: yesNew England Journal of Medicine, 2023
BACKGROUND The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied.
W. Zi   +60 more
semanticscholar   +1 more source

Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Tirofiban is a highly selective nonpeptide antagonist of glycoprotein IIb/IIIa receptor, which reversibly inhibits platelet aggregation.
Zhongming Qiu   +95 more
semanticscholar   +1 more source

Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis. [PDF]

open access: yesEur J Neurol
Background and purpose The aim of this study is to investigate the efficacy and safety of preoperative versus intraoperative tirofiban in patients with large vessel occlusion (LVO) due to large artery atherosclerosis (LAA).
Sun Z   +19 more
europepmc   +2 more sources

Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow‐up

open access: yesKaohsiung Journal of Medical Sciences, 2021
To investigate the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris (UA).
Li Deng   +3 more
doaj   +1 more source

Tirofiban-induced thrombocytopenia

open access: yesAnnals medicus, 2023
Tirofiban is a small non-peptide ligand-mimetic Glycoprotein (GP) IIb/IIIa inhibitor which can reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to prevent platelet aggregation.
Jun Wang, Dongna Zou
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy